APA

Rogers E., Bredin H., Butler M., Corcoran M., Egan E., Fennelly J., Grainger R., Aleer S. M., Dermott T. M., Mullins G., Tanner A., Twomey A. & Thornhill J. (20000501). Combined subcutaneous recombinant alpha-interferon and interleukin-2 in metastatic renal cell cancer: results of the Multicentre All Ireland Immunotherapy Study Group. : European urology.

Chicago

Rogers E, Bredin H, Butler M, Corcoran M, Egan E, Fennelly J, Grainger R, Aleer S M, Dermott T M, Mullins G, Tanner A, Twomey A and Thornhill J. 20000501. Combined subcutaneous recombinant alpha-interferon and interleukin-2 in metastatic renal cell cancer: results of the Multicentre All Ireland Immunotherapy Study Group. : European urology.

Harvard

Rogers E., Bredin H., Butler M., Corcoran M., Egan E., Fennelly J., Grainger R., Aleer S. M., Dermott T. M., Mullins G., Tanner A., Twomey A. and Thornhill J. (20000501). Combined subcutaneous recombinant alpha-interferon and interleukin-2 in metastatic renal cell cancer: results of the Multicentre All Ireland Immunotherapy Study Group. : European urology.

MLA

Rogers E, Bredin H, Butler M, Corcoran M, Egan E, Fennelly J, Grainger R, Aleer S M, Dermott T M, Mullins G, Tanner A, Twomey A and Thornhill J. Combined subcutaneous recombinant alpha-interferon and interleukin-2 in metastatic renal cell cancer: results of the Multicentre All Ireland Immunotherapy Study Group. : European urology. 20000501.